Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 17Head & Neck 9Gastrointestinal 4Thoracic 3Breast 3Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Endocrine 1CNS 1

Conditions

Brain Neoplasms 15Central Nervous System Neoplasms 12Ovarian Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Lung Neoplasms 6Glioma 6Glioblastoma 6Testicular Neoplasms 4Testicular Germ Cell Tumor 4Astrocytoma 4Teratoma 3Squamous Cell Carcinoma of Head and Neck 3Seminoma 3Pancreatic Neoplasms 3Neoplasms 3Melanoma 3Medulloblastoma 3Lymphoma, Non-Hodgkin 3Gliosarcoma 3Endodermal Sinus Tumor 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Thyroid Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Neuroectodermal Tumors, Primitive 2

Interventions

Temozolomide 23Bevacizumab 18Cyclophosphamide 9Carboplatin 7Lomustine 6Irinotecan 63-Iodobenzylguanidine 6Topotecan 5Radiotherapy 5Filgrastim 5Radiosurgery 4Nivolumab 4Everolimus 4Etoposide 4Busulfan 4sonidegib 3pembrolizumab 3olaparib 3fludarabine phosphate 3fludarabine 3antineoplaston AS 2-1 3antineoplaston A10 3Vincristine 3Thiotepa 3Sirolimus 3Melphalan 3IL13-PE38 3Drug Therapy 3Antilymphocyte Serum 3verubulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Paclitaxel × CNS × Clear all
NCT00479765 2022-06-22

A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGelâ„¢ in Subjects With Recurrent Glioma

Boston Scientific Corporation

Phase 1/2 Terminated
4 enrolled 5 charts
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡